Michigan Launches First-of-Its-Kind Opioid Settlement Tracking System

When billions of dollars began flowing into states from opioid litigation settlements, a critical question emerged: Who would ensure this money actually reaches the communities torn apart by addiction?

Michigan Attorney General Dana Nessel has just provided an answer that other states may soon follow. On May 14, 2026, her office unveiled a first-of-its-kind transparency system that combines detailed spending guidance with a public reporting dashboard tracking every dollar of opioid settlement money received and spent by local governments across the state.

A New Standard for Accountability

The initiative stems from a revised State-Subdivision Agreement negotiated in July 2025 between the Department of Attorney General and 86 Michigan Litigating Local Governments. This agreement mandated annual reporting and gave the Attorney General's office authority to issue guidance and request information about settlement expenditures.

"The opioid epidemic has caused immense damage to Michigan families and communities," Nessel said in announcing the new resources. "By providing spending guidance and accessible data, we are helping ensure that settlement funds remain focused on supporting recovery, prevention, and healing across our state."

The centerpiece is the Opioid Received/Expended Report, a living document that compiles data from local governments detailing how much funding each has received and where those dollars have gone. The preliminary report covers January 1, 2023, through December 10, 2025, and will continue to be updated as additional jurisdictions submit their figures.

What Qualifies—and What Doesn't

Alongside the tracking report, Nessel's office released comprehensive Settlement Spending Guidance that establishes clear parameters for appropriate fund allocation. The guidance includes a "Non-Remediation List"—expenditures that likely do not qualify as opioid remediation and will be updated regularly.

This clarity addresses a growing concern nationwide: the risk of settlement funds being diverted to purposes only tangentially related to the opioid crisis. In Arizona, for instance, a recent audit found $50.9 million in opioid settlement funds may have been improperly spent on prison hepatitis C treatment. Michigan's framework aims to prevent similar misallocation through upfront guidance rather than after-the-fact audits.

The Scale of Michigan's Response

The tracking system covers substantial financial resources. Michigan has already allocated more than $130 million through its fiscal year 2026 budget for opioid abatement, with the state health department positioned as a key partner in aligning investments with statewide strategy.

Additional funding is on the way. The state is set to receive another major infusion from the long-awaited multistate settlement with Purdue Pharma and the Sackler family—a deal that became legally effective in February 2026 and will ultimately direct $7.4 billion to participating states over 15 years.

Why Transparency Matters Now

The timing of Michigan's announcement reflects both opportunity and urgency. After years of litigation, settlement funds are finally flowing in volume. Without robust oversight mechanisms, there's a real risk that these resources—intended to address one of the deadliest public health crises in American history—could be absorbed into general budgets or spent on projects with minimal connection to addiction treatment and prevention.

Michigan's approach offers a potential model. By combining clear guidance with public reporting, the state creates multiple layers of accountability. Local governments know what's expected. Citizens can see where money is going. And the Attorney General's office maintains oversight authority to investigate concerns.

What This Means for Treatment Access

For people struggling with opioid addiction, the implications extend beyond bureaucratic transparency. Effective allocation of settlement funds directly translates to expanded access to medication-assisted treatment, naloxone distribution programs, recovery housing, and prevention initiatives.

The tracking system also enables better coordination. When local governments can see how neighboring jurisdictions are investing their funds, opportunities for regional collaboration become apparent. A county investing heavily in treatment capacity might partner with a neighboring community focusing on prevention to create a comprehensive continuum of care.

Looking Ahead

As Michigan's reporting database populates and the Non-Remediation List evolves, the state will accumulate valuable data about what works—and what doesn't—in opioid settlement fund allocation. This knowledge could inform not only Michigan's future decisions but also policy development in other states grappling with similar challenges.

The question now is whether other states will follow Michigan's lead. With tens of billions of dollars in opioid settlements flowing nationwide, the difference between robust transparency and minimal oversight could determine whether this unprecedented financial resource delivers on its promise to help communities heal.

For Michigan residents, the message is clear: the Attorney General's office has opened the books. What the data reveals—and how policymakers respond—will shape the state's addiction response for years to come.